A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group

BACKGROUND: E2104 was designed to evaluate the safety of two different strategies incorporating bevacizumab into anthracycline-containing adjuvant therapy as a precursor to a definitive randomized phase III trial. PATIENTS AND METHODS: Patients were sequentially assigned to one of two treatment arms...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Miller, K. D., O’Neill, A., Perez, E. A., Seidman, A. D., Sledge, G. W.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2012
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3265545/
https://ncbi.nlm.nih.gov/pubmed/21821545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdr344
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires